Protect Pharmaceutical Corp (PRTT)

[PEACHMAN]

PRTT has been a nice core holding for me along with RAFA and WUHN

[PEACHMAN]

I agree. I seldom post but PRTT is one of my most profitable holdings

[Investorr]

54,951,378 Outstanding Shares. I asked IR about float and I'm waiting to hear back.

https://www.otcmarkets.com/stock/PRTT/security

[weathervane]

Any idea what the float is? I've searched but find nothing. Or the most recent share structure.

[Investorr]

Yes. PRTT is a slam dunk. Buy and Hold! Same with its sister company $RAFA. Both will keep going up each week.

[weathervane]

I found that report by accident. Why is this board so quiet? Seems like a slam dunk eventually.

[Investorr]

WOW! A new report projects PRTT to be worth $39.14 per share per share! Current price $3.45.

Reverse Merger Underway With Protect Pharmaceutical Corp And Novgorod Would Increase PRTT Sales, Assets, And Growth Dramatically

Protect Pharmaceutical Corp. (PRTT: OTC) revitalizes farming soil and produces organic, toxin-free crops to meet the increasing global demand for agricultural sustainability initiatives
PRTT building 2 new production facilities in Europe projected to increase 2021 revenues by $60 million
Novgorod is an international food production company that is ranked as one of Russia’s 50 fastest growing companies with 2019 sales of $128,913,000 and growth of about 50% per year for past 2 years
PRTT announced Novgorod will acquire controlling interest of PRTT. Upon completion of merger and Novgorod’s reporting to GAAP accounting standards,the combined companies will trade as PRTT
Financial reports due within 60 to 90 days are expected to finalize merger and trigger higher share prices resulting from dramatic increases in sales, operations, and assets
About Protect Pharmaceutical Corp

Under the umbrella of Protect Pharmaceutical Corp. (PRTT: OTC), Agropharmacy provides sustainable products to revitalize farming soil, and produce more robust and abundant toxin-free crops in order to meet the increasing global demand for agricultural sustainability initiatives.

Aug. 03, 2020 Protect Pharmaceutical announced, “Protect Pharmaceutical’s Agropharm A Fertilizer Was Shown To Increase Crop Yields By As Much As 30%”. “This shows a very promising trend in Protect Pharmaceutical’s plans to become Europe’s leading bio-fertilizer provider” comments Angela Savcenco, Director of European Operations.

July 7, 2020 PRTT announced 2new installations in 2020. Agropharm organic fertilizer production sites will be launched in Slovenia and Spain to further develop our Agropharmacy program to increase the quality and quantity of organic food.

Savcenco commenting further said,“The two new installations will allow the company to supply demand within all boarders of the European Union. This also signals the transition from the active testing stage to active marketing. The installations in Slovenia and Spain will mean that the company should capture approximately 50 million Euro per year in new revenues once construction is completed. The company is targeting the new installations to be fully operational by the beginning of the 2021 planting."

Protect Pharmaceutical Corp and Novgorod Merger

September 15, 2020 Protect Pharmaceutical Corp announced an agreement to be acquired and merged with Novgorod which specializes in the production and sale of sugar, flour, cereals and other groceries. Actively successful in the Russian food market for over 15 years, Novgorod operates with such retail giants as AO Tander (Magnit), X5 Retail Group, OOO Lenta, AO Dixy South and others. Novgorod reported 9.7 Billion (RUB) (US $128,913,000 as of release) in revenues for 2019. Second quarter 2020 revenues were 3.7 (RUB) (US $49,173,000.00 as of release).

Under the agreed terms, Novgorod will acquire control of Protect Pharmaceutical Corp upon completion of the transition of Novgorod’s reporting to GAAP accounting standards. Protect Pharmaceutical Corp will continue to operate as a public company and the eventual resulting combined company will continue to trade under the symbol PRTT.

Protect Pharmaceutical Corp and Novgorod foresee incredible synergies from the transaction. Novgorod intends to use Protect Pharmaceutical products for its own production and Protect Pharmaceutical Corp will harness the market power of Novgorod as an incredible opportunity for expansion. “This is an amazing milestone for Protect Pharmaceutical. We have been searching for the right partner to expand and grow and in Novgorod we have found it,” states Angela Savcenco.

Current Market Comps

Five current market comps were selected and ranked from smaller to larger companies in similar industries. Average Price (Market Cap) to Sales Ratio of 16.7 to 1 was calculated and determined for this group of market comparison companies.

Arcadia Biosciences – (RKDA: Nasdaq)

Share price 09/16/2020 - $3.05

2019 Sales - $1.17 million

Market cap - $33 million

Price to Sales Ratio – 28.2

Marrone Bio Innovations (MBII: Nasdaq)

Share price 09/16/2020 - $1.20

2019 sales - $29.4 million

Market cap - $179 million

Price to Sales Ratio – 6

Precision BioSciences (DTIL: Nasdaq)

Share price 09/16/2020 - $5.93

2019 sales - $22.23 million

Market cap - $310 million

Price to Sales Ratio – 14

Beyond Meat (BYND: Nasdaq)

Share Price 09/16/2020 - $156.57

2019 sales - $298 million

Market cap - $9.8 billion

Price to Sales Ratio – 32

FMC Corp (FMC: NYSE)

Share Price 09/16/2020 - $110.67

2019 sales - $4.6 billion

Market cap - $14.7 billion

Price to Sales Ratio – 3.2

AVERAGE PRICE TO SALES RATIO = 16.7

Market Comp PRTT Share Price When Merger is Concluded

Potential PRTT share price based on current market comps of Price to Sales Ratio of 16.7 to 1 and combined 2019 sales exceeding $128,913,000 and 55 million shares outstanding is $39.14 per share.

With additional sales from the 2 new production facilities coming on line at the beginning of the 2021 planting season, sales are expected to increase by $60 million annually which could increase PRTT share price by $18.21 per share to well beyond $39.14 per share to $57.34 sometime in Q2/Q3 2022 when a full year sales is reported for the new production facilities.

The trend to lower Sales to Price Ratio for larger companies suggests that as PRTT grows, the ratio will decrease accordingly and share price expectations will be adjusted accordingly.

When the PRTT and Novgorod reverse merger is concluded as announced and when Novgorod sales are combined with PRTT, then the potential and likelihood for substantially higher PRTT share prices approaching the current market comp of 16.7 to 1 is reasonable to assume and to expect.

Fair Market Value should not be expected to be achieved immediately upon the close of the merger, but will likely take some time for investors to learn about this compelling story. The time to realize full Fair Market Value is never known exactly and can be influenced by many factors outside the world of PRTT. That time is greatly determined by visibility in the investment world or in other words by “Investor Awareness.”

Most Recent Protect Pharmaceuticals Until Audited Financials are Released Q4 2020

Conclusion

Based on existing operations and growth of Protect Pharmaceuticals Corp combined with the announced reverse merger of Novgorod into PRTT, current shares of PRTT appear to be an outstanding bargain for astute investors. The most notable risk is the exposure to the merger not materializing as planned. With the merger announcement already made and the current auditing of financials underway, the risk seems low and the reward seems exceptionally high.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

https://seekingalpha.com/instablog/21922151-bioresearch-alert/5498768-reverse-merger-underway-protect-pharmaceutical-corp-and-novgorod-increase-prtt-sales-assets

[madtrader2132]

https://seekingalpha.com/instablog/21922151-bioresearch-alert/5498768-reverse-merger-underway-protect-pharmaceutical-corp-and-novgorod-increase-prtt-sales-assets

[Investorr]

$PRTT News! Wow! Novgorod had $49,173,000 in revenues last quarter!

http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200915:nGNX2SQBHB

[AskMuncher]

$PRTT Protect Pharmaceutical’s Agropharm A Fertilizer Shown To Increase Crop Yields By As Much As 30%
Press Release | 08/03/2020
Sevnica, Slovenia, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.“OTC:(PRTT)” is pleased to announce another successful application of its Agropharm A product fertilizer in Istria, Croatia. Agropharm A was tested on a lettuce farm that produces snail feed for industrial snail production. The product was applied to the client’s field in three treatments in the following manner:

Method and time of treatment with Agropharm A:

- First treatment (July 8, 2020): Soaking seedlings (containers) in concentration 2:50 (2L css:50L H2O) for 1 minute before transplanting;
- Second treatment (July 13, 2020): 7 days after transplanting, foliar use (1:50);
- Third treatment (July 23, 2020): Foliar use (1:50), 15 days after first use combined with a fungicide application (Sygnum) for prevention of disease (Botrytis Cinerea);

- The first harvest was collected on August 2nd, 2020
Compared with the control field, lettuce treated with Agropharm A increased both leaf size by 30% bigger and crop weight by at least 25%.

“So far every demonstration of the Company’s products on industrial agricultural locations has had a 100% success rate in increasing crop yields and resulted in new orders placed for our products. This shows a very promising trend in Protect Pharmaceutical’s plans to become Europe’s leading bio-fertilizer provider” comments Angela Savcenco, Director of European Operations.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

[whytestocks]

News: $PRTT Protect Pharmaceutical's Agropharm A Fertilizer Shown To Increase Crop Yields By As Much As 30%

Sevnica, Slovenia, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” is pleased to announce another successful application of its Agropharm A product fertilizer in Istria, Croatia. Agropharm A was tested on a lettuce farm that produces snail feed for...

In case you are interested PRTT - Protect Pharmaceutical's Agropharm A Fertilizer Shown To Increase Crop Yields By As Much As 30%

[Investorr]

Can’t stop, won’t stop

[makinezmoney]

$PRTT: This is just shooting straight up..... 3.20


No stopping it whatsoever



GO $PRTT

[Investorr]

Thin baby. No one is selling and we’re just getting started.

[Marty Byrd]

54.9M shares outstanding. Maybe about 10M in float

[makinezmoney]

$PRTT: Is this really only 1Milly OS ????????


Serious ???


Whats the Float on this ?



Asking for a friend



GO $PRTT

[Eurotradr]

You would be 100% correct on all fronts.

[Investorr]

Big assets being accumulated! It will be reflected eventually in the price. I would assume that they are planning a uplist to a higher exchange.

[Eurotradr]

This stock is ready to explode. Just look at the value of assets being accumulated yet to be reflected in the price... COME ON NOW!!!

[Investorr]

Only 54,951,378 Outstanding Shares! Super Low Float. Diamond in the Ruff!

https://www.otcmarkets.com/stock/PRTT/security

[Investorr]

"The installations in Slovenia and Spain will mean that the company should capture approximately 50 million Euro per year in new revenues once construction is completed. The company is targeting the new installations to be fully operational by the beginning of the 2021 planting," comments Director of European Operations, Angela Savcenco."

https://www.otcmarkets.com/stock/PRTT/news/Protect-Pharmaceutical-Announces-Construction-of-Two-New-Agropharm-Production-Sites?id=266955

[Investorr]

Huge PRTT news! PRTT $50m Euro a Year! Wow. What's that equal like $56 Million USD? Nice!

https://www.bloomberg.com/press-releases/2020-07-07/protect-pharmaceutical-announces-construction-of-two-new-agropharm-production-sites

[AskMuncher]

$PRTT Protect Pharmaceutical Successfully Deploys Agropharm A, Obtains DTC Eligibility
Press Release | 06/19/2020
Sevnica, Slovenia, June 19, 2020 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Protect Pharmaceutical Corp is pleased to announce successful use of its Agropharm A biologically clean fertilizer on the fields of Slovenia. Among other uses, the product was used by Green Drop D.O.O. Slovenia on its Spelt production. Spelt is one of the ingredients that Green Drop D.O.O. uses in its biologically clean creams and various kinds of food supplement products. Agropharm A was applied on the seedlings of Spelt and later on the fields. One control field was planted without Agropharm A use. The crop of Spelt was collected this week. The results show tremendous advantages of using Agropharm A. Spelt crop showed a 28% weight increase compared to the control field. Also, when producing the juice needed for the products of Green Drop D.O.O., the crop produced with Agropharm A showed 33% more yield in the juice compared to the crop collected from the control field.

Agropharm A and other Company products were also used in this 2020 season on various agricultures, including wine grapes, cannabis & wheat. All of the cultures already show the incredible advantages Agropharmacy products. The Company shall inform its shareholders on the more precise results of use of its products in 2020 season as soon as it receives the statistics from its customers.

Further, the Company is pleased to announce that it has obtained DTC eligibility with The Depository Trust Company ("DTC") for its shares listed on OTC Markets. The DTC is a subsidiary of the Depository Trust & Clearing Corporation ("DTCC"), a U.S. company that manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through the DTC are considered "DTC eligible." This electronic method of clearing securities accelerates the settlement process for investors, enabling the stock to be traded over a wider network of brokerage firms, achieved by adhering to compliance standards.

The Company wants to thank V Stock Global for their assistance in obtaining DTC eligibility.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

[AskMuncher]

$PRTT OTC DISCLOSURE & NEWS SERVICE
Protect Pharmaceutical Successfully Deploys Agropharm A, Obtains DTC Eligibility
Press Release | 06/19/2020
Sevnica, Slovenia, June 19, 2020 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Protect Pharmaceutical Corp is pleased to announce successful use of its Agropharm A biologically clean fertilizer on the fields of Slovenia. Among other uses, the product was used by Green Drop D.O.O. Slovenia on its Spelt production. Spelt is one of the ingredients that Green Drop D.O.O. uses in its biologically clean creams and various kinds of food supplement products. Agropharm A was applied on the seedlings of Spelt and later on the fields. One control field was planted without Agropharm A use. The crop of Spelt was collected this week. The results show tremendous advantages of using Agropharm A. Spelt crop showed a 28% weight increase compared to the control field. Also, when producing the juice needed for the products of Green Drop D.O.O., the crop produced with Agropharm A showed 33% more yield in the juice compared to the crop collected from the control field.

Agropharm A and other Company products were also used in this 2020 season on various agricultures, including wine grapes, cannabis & wheat. All of the cultures already show the incredible advantages Agropharmacy products. The Company shall inform its shareholders on the more precise results of use of its products in 2020 season as soon as it receives the statistics from its customers.

Further, the Company is pleased to announce that it has obtained DTC eligibility with The Depository Trust Company ("DTC") for its shares listed on OTC Markets. The DTC is a subsidiary of the Depository Trust & Clearing Corporation ("DTCC"), a U.S. company that manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through the DTC are considered "DTC eligible." This electronic method of clearing securities accelerates the settlement process for investors, enabling the stock to be traded over a wider network of brokerage firms, achieved by adhering to compliance standards.

The Company wants to thank V Stock Global for their assistance in obtaining DTC eligibility.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

[Investorr]

These guys are gonna have so many assets and flying under the radar. No worries, buying comes in when they start releasing earnings and uplist to a higher exchange.

[Eurotradr]

Protect Pharmaceutical Acquires 60 Hectares in Selva Girona to Showcase Agropharmacy Products and Mastnak Wines
May 20, 2020, 10:05 AM EDT

Sevnica, Slovenia, May 20, 2020 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” announces the acquisition of the Can Noguera property located in the heart of Selva Girona region in Spain. The property consists of 60 hectares of arable land, 390 hectares of forests with more than 100 km of forest tracks, 6 mineral and freshwater wells and 3000 square meters of built properties, including historical village and farm construction built between 16th and 19th Centuries. The property lays in one of the most beautiful and attractive places in the Selva, an ideal enclave with lush mountains belonging to the Massis de Cadiretes natural park. It is 10 minutes from the town of Tossa de Mar that is considered the blue paradise of the Costa Brava, located in the extreme northeast of Catalonia, about 86 kilometers south of the French border. These were Salvador Dalí's favorite places, whose museum is nearby.

The company intends to use the newly-acquired property to expand operations of the Mastnak Winery and open a demonstration showcase for the entire line of its bio-friendly fertilizer products. Existing historical properties will be used for hosting shows and events--all designed to increase sales of the company’s line of Agropharmacy products. The new property will operate in conjunction with recently acquired Hotel Albons.

“Can Noguera represents an incredible value that the company managed to acquire during the difficult times of pandemic recovery in Europe. The property will complement and promote the company’s line of Agropharmacy products and fuels growth to the incredibly popular line of Mastnak Wines,” comments Director of European Operations Angela Savcenco.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For more information contact:
Protect Pharmaceutical Corp.
[phone]
[e-mail]

Attachment

2020 Protect Pharmaceutical Corp

[Eurotradr]

Protect Pharmaceutical Acquires the Hotel Albons in Spain and Adds New Director from the Hospitality Sector - https://www.bloomberg.com/press-releases/2020-05-12/protect-pharmaceutical-acquires-the-hotel-albons-in-spain-and-adds-new-director-from-the-hospitality-sector

No cash exchanged, no dilution. We are clear for takeoff!!

[Riblindman]

Does anyone know why this got flagged for promo?

[SPARK]

$PRTT..been easy money~

[TradeForProfits]

boom $PRTT today... made some coin, forgot i had this sitting in account from the RS/average up share thing from years ago.

[SPARK]

$PRTT Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information - PRTT (04-27-2020)
https://www.otcmarkets.com/stock/PRTT/disclosure

[SPARK]

$PRTT Outstanding Shares 54,951,378 04/20/2020
Restricted 50,196,049 04/20/2020
Unrestricted 4,755,329 04/20/2020

[ABBAZABBA]

Anyone Home? https://www.otcmarkets.com/filing/html?id=13266194&guid=SSStUKCL2qKg43h

[$hellKing]

I keep trying to get shares and people alway get them and i miss the bid drops. hope this does a EDRG

[tedpeele]

from newest filing:

On June 5 ,, 201 8 ,(the “Closing” or “ Closing Date ”), StartRenewable sold, assigned and conveyed the Purchased Shares to the Buyer for an aggregate purchase price of $2 3 0,000, or approximately $0. 0225159 per share. The Purchased Shares represented approximately 70 . 4 % of the Company’s issued and outstanding shares of Common Stock as of the Record Date. In addition the Company purchased a 20% minority Member Interest in J & Y Property Preservation LLC in exchange for 10,000,000 shares of the company’s common stock. This increased the Company’s outstanding shares to 24,501,460 as of the Record Date.

[MadeBucksOnThis]

https://backend.otcmarkets.com/otcapi/company/sec-filings/12797705/content/html

[today32]

Any updates from StartCapital or Eight Dragons? Not sure why we haven't seen an uptick since the stock swap, given the roughly $4.50/share evaluation.

[$hellKing]

Hope they keep filing. Getting real tired of these going dark all of the time.

[funnyG986]

agree. Only around 100k in the float

[today32]

Great news... Very few shares on the ask, this one can pretty much go where it wants to.

[funnyG986]

PRTT and EDRG announced a stock swap today after market. Company is having a new name as well

Concurrent with this consulting agreement the company completed a stock swap with Eight Dragons receiving 3,000,000 common shares of Eight Dragons for 6,100,000 common shares of PRTT. StartCapital is a new financing company that specializes in non-equity based funding for start-up companies. Protect Pharmaceutical Corporation will be renamed to StartCapital, Inc., in addition to its own financing activities, will be a source for financing for companies in the Eight Dragon ecosystem.

EDRG trading at $9 per share now. does it mean PRTT will hit $4.5 based on the swap agreement ? LOL

http://ih.advfn.com/p.php?pid=nmona&article=75242875&symbol=PRTT

[today32]

8k out: https://www.sec.gov/Archives/edgar/data/1493526/000116552717000157/g8446.htm

[$hellKing]

Another year and they havent even gotten the initial drilling done? 2 years almost.... What a sucky hold this has been. Sell the co to another person why can do something faster....

[$hellKing]

Plan of Operation


Following the sale of patents, patent applications and technologies in 2011, we have endeavored to explore possible plans for the remaining patents and new generation drug delivery technologies acquired in 2010. However, without adequate personnel with the requisite scientific expertise, we found it difficult to further develop the technologies and endeavored to explore alternative business ventures. Following the acquisition of certain mining and mineral claims and leases in September 2014, we have directed our focus on the initial exploration of the acquired properties to determine whether there is commercial potential. We are now in the process of developing a definitive plan for the initial exploration of our claims.


We are classified or considered an exploration stage mining company, which is defined as a company engaged in the search for mineral deposits or reserves of precious and base metal targets, which are not in either the development or production stage. We have no known mineral reserves on our properties and our proposed preliminary studies of the claims is intended to be exploratory in nature.


Our current plan is to finalize and initiate an exploration program, to identify our objectives and anticipated growth for the next 12 months, and identify our cash requirements to fulfill our business objectives. We will need to raise additional funds during the next 12 months to complete our exploration commitments and to pay for general business and operating expenses. We estimate that we will need up to $100,000 during the next twelve months to facilitate an exploration program. Management plans to explore a possible private placement of our securities and/or debt financing to raise the additional fund, although no definitive plan has been formulated and there can be no assurance that we will be able to realize the necessary funds.


If exploration results do not warrant drilling or further exploration, we will most likely suspend operations on the property. In that event, we would need to seek additional exploration properties and additional funding with which to conduct the work. If we are unable to obtain additional financing or additional properties, we may not be able to continue active business operations.


If we are able to complete an initial exploration programs and successfully identify a mineral deposit, we will need substantial additional funds for drilling and engineering studies to determine whether any identified mineral deposit is commercially viable. If we are unable to raise additional funds for this work or secure a strategic partner, we would be unable to proceed, even if a mineral deposit is discovered and is believed to be commercially viable.


We do not anticipate conducting any product research or development over the next 12 months. Also, we do not expect to make any major equipment purchasers or make any significant capital expenditures in the immediate future unless we have the necessary funds. We do not have employees and do not expect to add employees over the next 12 months, except for part-time clerical assistance on an as-needed basis and possibly engaging outside advisors or consultants as requisite funds are available. We anticipate that our current management team will satisfy our everyday operating requirements for the foreseeable future.


Because we currently have limited cash, it may be necessary for officers, directors or stockholders to advance funds and we will most likely accrue expenses until a funding can be accomplished. Management intends to hold expenses to a minimum and to obtain services on a contingency basis when possible. Further, we expect directors to defer any compensation until such time as we have sufficient funds. We have not yet entered into any arrangements or definitive agreements to use outside advisors or consultants or to raise any capital.


We are currently exploring possible funding sources, but we have not entered into any arrangements or agreements for funding as of this time. If we are unable to raise the necessary funding, our research and development plans will be delayed indefinitely. There can be no assurance that we will be able to raise the funds necessary to carry out our business plan on terms favorable to the company, or at all.

[$hellKing]

Nothing new in 10k I dont think still drilling planning etc


But good to know the OS is 99.9% held by insiders.lol

Geoff Williams 907,286 46.5 % 2681 East Parleys Way, Suite 204 Salt Lake City, UT 84109 5% Stockholders Edward F. Cowle 102,750 5.2% 70 Garth Road, Apt. 4A Scarsdale, NY 10583 H. Deworth Williams 937,063 48.1% 2681 East Parleys Way, Suite 204 Salt Lake City, UT 84109 All directors and officers 2,286 0.1% a group (2 person) 1949385

[$hellKing]

Looks like CEO is doing deals. He sold BTLK for a merger. Now PRTT is up? Looks like BTLK will go purty high based on low OS. PRTT float and OS so low and NITE has almost the whole float. Wish he would lower ask a bit instead of being at 1.00 the whole time.

[$hellKing]

It looks like now people who bought after RU are selling. I still have mine but dont have time to sit at .80 .90 for 1k more.

[$hellKing]

I would still average down but you dont know when a rouge sell will come in. So MM gets the shares and will sell them for higher. People should give a heads up on a dump. At least some people here will get some.

[$hellKing]

I bought a little too high thinking they would be faster to put something out. It looked like they were with the mining claims and the UREE connection. Now it looks like crap. People will dump their 100 for 80 bucks until it goes to a few hundred at .10 then it might bounce.

[ottoman]

from 80 to .80 lol. 1% of post-split price. nice company.